Skip to main content

Rebecca Hyde

Ms Hyde is Executive Vice President, Global Commercialization.

Authored Items
Orphan Drug Pricing and Payer Management in the United States: Are We Approaching the Tipping Point?
Rebecca Hyde, Kavita V. Nair, PhD, Diana Dobrovolny
January/February 2010, Vol 3, No 1 in Practice Management
Last modified: September 6, 2013